Drug CategoryDrugIHD Dosing

Administration Timing Around HD Session

AntifungalsFlucytosine37.5mg/kg PO QHDAdminister Post-HD

Molecular Weight    (Da)

Excreted Unchanged (%)Normal Half-Life (Hours)ESRD Half-Life (Hours)Plasma Protein Binding (%)Volume of Distribution (L/kg)Dialytic Plasma Clearance (ml/min)% Dialyzed
129903-675-200<100.6N/AReadily (low flux)


  • Aronoff GR, Bennett WM, Berns JS, Brier ME, Kasbekar N, Mueller BA, et al. Drug Prescribing in Renal Failure. Philadelphia: American College of Physicians;2007.
  • Banks R, Williams A, Glover S, Burton P, Warnock D, Mackenzie C. Disseminated cryptococcosis in a patient receiving chronic haemodialysis. Postgraduate medical journal 1985; 61(718), 745-7.
  • Block E, Bennett J, Livoti L, Klein W. Flucytosine and Amphotericin B: Hemodialysis Effects on the Plasma Concentration and Clearance. Annals of internal medicine 1974; 80, 613-7.
  • Christopher T, Graham, Blair A, Forrey A, Cutler R. Hemodialyzer Clearances of Gentamicin, Kanamycin, and Flucytosine, with a Technique for Planning Therapy. Journal of Pharmacokinetics and Biopharmaceutics 1976; 4(5), 427-41.
  • DrugBank [Online]. 2012 Apr 12 [cited 2012 May 6]; Available from: URL: http://www.drugbank.ca/drugs/DB01099
  • Gandhi B, Bahadur M, Dodeja H, Aggrwal V, Thamba A, Mali M. Systemic fungal infections in renal diseases. Journal of postgraduate medicine 2005; 51(Suppl 1), S30-6.
  • Polak A. Pharmacokinetics of amphotericin B and flucytosine. Postgraduate medical journal 1979; 55(September), 667-670.